NEWS

ME Therapeutics press releases, media coverage and scientific findings

CEOCFO Magazine: Discovering and Developing Drugs that Reprogram Immune Cells in Patients

Trade and Invest BC: Advanced Antibody Discoveries — Companies to Watch

ME THERAPEUTICS SCIENTIFIC AND CORPORATE UPDATE

ME THERAPEUTICS ATTENDING JP MORGAN HEALTHCARE CONFERENCE

CSE Magazine: On a mission to reprogram the human immune response to cancer

Breaking Cancer News: Is In vivo CAR the Next Frontier of Cancer Therapy?

ME THERAPEUTICS GRANTED LICENCE FOR CD22 NANOBODY ASSET TO EXPAND NEXT-GEN IN VIVO CAR CELL THERAPY PROGRAM

ME THERAPEUTICS ADDED TO CSE25 INDEX

ME THERAPEUTICS SECURES U.S. PATENT FOR LEAD CANDIDATE AND ADVANCES BROADER THERAPEUTIC PROGRAMS

Vancouver Guardian: Homegrown Business with Salim Dhanji of ME Therapeutics

CSE TV: Salim Dhanji on Targeting Immune Suppression in Cancer

Techcouver: ME Therapeutics Secures Investment to Advance R&D for Biotech Innovation

Keep up to date by subscribing to our mailing list